Tuberculosis verrucosa cutis associated with tuberculous lymphadenitis

Citation
Mb. Pereira et al., Tuberculosis verrucosa cutis associated with tuberculous lymphadenitis, INT J DERM, 39(11), 2000, pp. 856-858
Citations number
9
Categorie Soggetti
Dermatology
Journal title
INTERNATIONAL JOURNAL OF DERMATOLOGY
ISSN journal
00119059 → ACNP
Volume
39
Issue
11
Year of publication
2000
Pages
856 - 858
Database
ISI
SICI code
0011-9059(200011)39:11<856:TVCAWT>2.0.ZU;2-Y
Abstract
A 34-year-old man presented with a large cutaneous lesion on his left thigh that had started as a small papule when he was 13 years of age. The lesion had enlarged slowly over the last 21 years. The patient had received bacil lus Calmette-Guerin (BCG) vaccination in childhood. The family history was significant for tuberculosis. Clinical examination revealed a large, purplish-red, indurated plaque measu ring 30 X 29 cm on the left thigh, extending to the buttock area. The edges of the lesion had a serpiginous contour with an involuted center (Fig. 1). A left inguinal lymph node was palpated. Chest X-ray and blood cell count were normal. No other focus of disease was identified. Laboratory testing for human immunodeficiency virus (HIV) infe ction was negative. Purified protein derivative (PPD) intradermal injection disclosed a 19-mm skin induration. Both the cutaneous lesion and the inguinal lymph node were biopsied. Histop athologic sections of the skin fragment showed epidermal hyperkeratosis, ne ovascular proliferation, and a dense dermal lymphocytic infiltrate. The his topathology of the lymph node demonstrated few granulomas with focal areas of central necrosis. Staining for fungus was negative. Ziehl-Neelsen staining was negative on bo th the skin and lymph node specimens. Culture for fungus and Leishmania sp. was negative. Tissue culture on Lowenstein-Jensen medium from skin and lym ph node was positive for Mycobacterium colonies after 5 and 7 weeks, respec tively. Multidrug therapy was instituted with rifampin 600 mg/day, isoniazid 400 mg /day, and pyrazinamide 2 g/day for 2 months, and then rifampin 600 mg/day a nd isoniazid 400 mg/day alone for the next 4 months. An excellent response was obtained at the end of treatment (Fig. 2).